pharmaceutical stocks

  • Featured Story

    Biotech companies are racing to develop a coronavirus vaccine. And investors are racing to profit from it. In fact, CBSNews reported on May 28 that the rush created a $200 billion stock market bubble.

    Many flocked to Gilead Sciences, Inc. (NASDAQ: GLD) after the company announced its "Remdesivir" treatment for COVID-19.

    But you don't have to follow the crowd. And you don't have to cast a mindless net over just any biotech stocks you find in the COVID-19 crisis. We're going to share with you some of the best pharma stocks to buy right now. These could be some of the most promising pharmaceuticals for coronavirus vaccine and treatment hopes.

    Read more here...

Article Index

Sorry, no content matched your criteria.